PRDX3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.627000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.820400E-01
Normal-vs-Stage2
6.925000E-01
Normal-vs-Stage3
1.520580E-01
Normal-vs-Stage4
8.572400E-01
Stage1-vs-Stage2
6.220400E-01
Stage1-vs-Stage3
3.146800E-01
Stage1-vs-Stage4
8.296400E-01
Stage2-vs-Stage3
2.332000E-01
Stage2-vs-Stage4
4.120400E-01
Stage3-vs-Stage4
2.617200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.413400E-01
Normal-vs-AfricanAmerican
5.723400E-01
Normal-vs-Asian
6.041800E-01
Caucasian-vs-AfricanAmerican
1.781620E-01
Caucasian-vs-Asian
6.522000E-01
AfricanAmerican-vs-Asian
1.753030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.731600E-01
Normal-vs-Female
8.888000E-01
Male-vs-Female
2.955200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.094800E-01
Normal-vs-Age(41-60Yrs)
8.615800E-01
Normal-vs-Age(61-80Yrs)
6.200200E-01
Normal-vs-Age(81-100Yrs)
6.717400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.881800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.152600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.189600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.831560E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.486600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.920800E-01
Normal-vs-Daily Drinker
6.446400E-01
Normal-vs-Weekly Drinker
4.546200E-01
Normal-vs-Occasional Drinker
5.909000E-01
Normal-vs-Social Drinker
6.618200E-01
Non Drinker-vs-Daily Drinker
6.584000E-01
Non Drinker-vs-Weekly Drinker
9.566600E-01
Non Drinker-vs-Occasional Drinker
1.886020E-02
Non Drinker-vs-Social Drinker
5.210800E-01
Daily Drinker-vs-Weekly Drinker
7.069600E-01
Daily Drinker-vs-Occasional Drinker
5.947900E-02
Daily Drinker-vs-Social Drinker
8.722400E-01
Weekly Drinker-vs-Occasional Drinker
4.200100E-02
Weekly Drinker-vs-Social Drinker
5.830000E-01
Occasional Drinker-vs-Social Drinker
9.786300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.169240E-01
Normal-vs-Grade 2
2.267900E-02
Normal-vs-Grade 3
2.550300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.409200E-01
Grade 1-vs-Grade 3
7.716600E-01
Grade 1-vs-Grade 4
1.169240E-01
Grade 2-vs-Grade 3
7.124200E-01
Grade 2-vs-Grade 4
2.267900E-02
Grade 3-vs-Grade 4
2.550300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.547000E-01
Normal-vs-NonDiabetic
6.603200E-01
Diabetic-vs-NonDiabetic
7.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.462600E-01
Normal-vs-NoPancreatitis
6.925400E-01
Pancreatitis-vs-NoPancreatitis
9.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.027000E-01
Normal-vs-N1
6.896600E-01
N0-vs-N1
3.968200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.714200E-01
Normal-vs-TP53-NonMutant
8.340200E-01
TP53-Mutant-vs-TP53-NonMutant
2.128800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
